Hydroxychloroquine & Chloroquine Market: Introduction

  • Hydroxychloroquine and chloroquine belong to the antimalarial drug class and are primarily recommended for preventing and treating acute attacks of malaria. This drug is also recommended for the treatment of discoid lupus erythematosus, systemic lupus erythematosus, in rheumatoid arthritis patients, and other autoimmune conditions. Chloroquine is also preferred for the treatment of different type of parasites. The two drugs are administered through the oral route. These drugs are derived from quinoline molecule and have similar clinical indication and side effects. Hydroxychloroquine is widely used as anti-rheumatic, which makes its different from chloroquine. The two drugs vary in terms of therapeutic toxicity and dosage.
  • Recently, the FDA issued guidelines for the usage of hydroxychloroquine and chloroquine for treatment of COVID-19. The benefits and efficacy of hydroxychloroquine and chloroquine in the treatment of coronavirus 2 (SARS–CoV-2) have been identified in the clinical trials carried out in March 2020. However, the data to support this study is limited and the drugs have not been proven completely safe for the treatment of COVID-19.

Are you a start-up willing to make it big in the business? Grab an exclusive PDF sample of this report

Key Drivers and Restraints of Global Hydroxychloroquine & Chloroquine Market

  • Increase in the export and import of hydroxychloroquine and chloroquine across regions, especially due to COVID-19 pandemic, rise in prevalence of malaria, rheumatoid arthritis, and other autoimmune diseases is projected to drive the global hydroxychloroquine & chloroquine market. Import of hydroxychloroquine & chloroquine drugs in the U.S., Germany, Italy, Spain and other countries in Europe is likely to propel the global market. Increase in incidence of COVID-19 since December 2019 across the globe is a major factor boosting the demand for hydroxychloroquine & chloroquine. According to statistics, there were around 3.45 million confirmed cases of COVID-19 globally as of April 2020, which drives the demand for hydroxychloroquine and chloroquine. On March 28, 2020, the FDA issued emergency use authorization for distribution of hydroxychloroquine and chloroquine to patients suffering from COVID-19 who could not be part of clinical trials.
  • According to HHS, Sandoz donated 30 million doses of hydroxychloroquine sulfate to the Strategic National Stockpile and Bayer donated 1 million doses of chloroquine phosphate for patients to manage COVID-19 condition. These are considered potential drugs in treating COVID-19 patients. All the above factors are likely to propel the global hydroxychloroquine & chloroquine market. However, shortage of supply of hydroxychloroquine and chloroquine is projected to restrain the demand for the drugs across the globe.

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report

North America to Lead Global Hydroxychloroquine & Chloroquine Market

  • In terms of region, the global hydroxychloroquine & chloroquine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global hydroxychloroquine & chloroquine market during the forecast period. This is attributed to increase in burden of COVID-19, well-developed health care infrastructure, increase in import of hydroxychloroquine & chloroquine drugs, ongoing clinical trials for these drugs to be potential treatment, and stringent FDA policies. Various agencies are working toward ensuring regular supply of the drugs as per rising demand. This is anticipated to augment the hydroxychloroquine & chloroquine market in the region. Certain research & clinical studies have indicated that the combination of hydroxychloroquine sulfate and azithromycin has shown potential in the treatment of COVID- 19. Recommendation of hydroxychloroquine and chloroquine for the treatment of rheumatoid arthritis, systemic lupus erythematosus (SLE), and other autoimmune diseases is expected to augment the hydroxychloroquine & chloroquine market in the region.
  • Europe was the second largest market for hydroxychloroquine and chloroquine in 2019, followed by Asia Pacific. Rise in demand for these drugs due to the COVID-19 pandemic is likely to boost the growth of the hydroxychloroquine & chloroquine market in Europe. Moreover, increase in cases of rheumatoid arthritis and other autoimmune condition is projected to fuel the growth of the hydroxychloroquine & chloroquine market in Europe. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period, owing to COVID-19 pandemic and export of hydroxychloroquine & chloroquine to developed countries. India is considered the largest exporter of hydroxychloroquine and chloroquine owing to large production and streamlined supply chain.

Key Players Operating in Global Hydroxychloroquine & Chloroquine Market

The global hydroxychloroquine & chloroquine market is fragmented, with the presence of large number of players. Major players operating in the global hydroxychloroquine & chloroquine market are:

  • Zydus Cadila
  • Prasco Laboratories
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sanofi
  • Bristol-Myers Squibb
  • Janssen Global Services, LLC
  • AstraZeneca
  • Other Prominent Players

Global Hydroxychloroquine & Chloroquine Market: Research Scope

Global Hydroxychloroquine & Chloroquine Market, by Dosage

  • 100 mg
  • 200 mg
  • 250 mg
  • 500 mg

Global Hydroxychloroquine & Chloroquine Market, by Application

  • COVID-19
  • Rheumatoid Arthritis
  • Malaria
  • Others

Global Hydroxychloroquine & Chloroquine Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Hydroxychloroquine & Chloroquine Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Hydroxychloroquine & Chloroquine Market